Tuesday, January 22, 8:15pm – 9:45pm
Congregation Beth Am
In the 1970s, an awareness campaign about Tay-Sachs began in the Jewish community, and today, through genetic counseling, the disease has been almost completely eliminated in the Jewish population.
But as we understand more about the genome, genetic mutations for other diseases and susceptibilities have been discovered to be more prevalent among Ashkenazi Jews—for example, mutations in the BRCA genes, which are associated with a higher risk of breast and ovarian cancer. The mutations that cause Gaucher’s disease and cystic fibrosis are also more common in our community.
Elad Ziv, MD, professor of medicine at UC San Francisco, will describe what is known from genetics about the history of the Ashkenazi Jewish population. His talk will also address some of the research about BRCA genes. Professor Ziv’s own research focuses on human genetics of cancer susceptibility and hematological traits.
Dr. Elad Ziv is a primary care physician in general internal medicine at Mount Zion. A professor in the UCSF Department of Medicine, Ziv’s research focuses on the genetic epidemiology of breast cancer and other age-related diseases. He also studies groups of mixed ethnicity to understand the relationship between environmental and genetic risk factors in explaining differences in cancer incidence.
Dr. Ziv received his medical degree and completed a residency in internal medicine at UCSF. He then completed a fellowship in internal medicine at the San Francisco Veterans Administration Medical Center and later the UCSF General Internal Medicine Clinical Research Fellowship.
Post archive date: Tuesday January 22nd, 2019